API | remdesivir

remdesivir (Veklury) Report issue

Small molecule Approved ^FDA Fast Track ^FDA Priority Review ^FDA

AACT

Active Ingredient History

NOW

Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. During the COVID‑19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in numerous countries. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanism of Action:
- Polymerase acidic protein (Influenza A virus (strain A/Wilson-Smith/1933 H1N1) (Influenza A virus(strain A/WS/1933 H1N1))) ^UniProt
- RNA-directed RNA polymerase catalytic subunit (Influenza A virus (strain A/Wilson-Smith/1933 H1N1) (Influenza A virus(strain A/WS/1933 H1N1))) ^UniProt
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

Drug Pricing (per unit)

United States

$386.7300 - $389.2500

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

gs-5734

Organizations (109)

Research & Development (109)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (1)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (11)

Approved Indications (1)

COVID-19 (approved 2020)

Experimental Indications - Clinical Trial Phases 1-4 (11)

Coronavirus Infections (Phase 3)

COVID-19 (Phase 4)

Drugs, Investigational (Phase 3)

Ebolavirus (Phase 2/Phase 3)

Healthy Volunteers (Phase 1)

Hemorrhagic Fever, Ebola (Phase 2)

HIV Infections (Phase 2)

Pneumonia (Phase 4)

Respiratory Distress Syndrome (Phase 2/Phase 3)

SARS-CoV-2 (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 69
# of Trial Organizations: 109

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue